Number of gene therapies quarterly by phase 2021-2023
As of Q3 2023, almost three quarters of all gene therapies in the pipeline were still in the preclinical phase. This statistic shows the quarterly number of gene therapy products in the pipeline from Q4 2021 to Q3 2023, by development phase.